|
3040
|
Abivertinib
|
Potent oral, irreversible, third-generation EGFR TKI with selectivity for mutant EGFRs |
€95.00
|
|
1986
|
AST 1306 tosylate
|
ErbB2 and EGFR inhibitor |
€105.00
|
|
2563
|
AZD 3759
|
Potent, orally active, brain-penetrant, EGFR tyrosine kinase inhibitor |
€85.00
|
|
2342
|
AZD 9291
|
Potent oral, irreversible, third-generation EGFR TKI with selectivity for mutant EGFRs |
€95.00
|
|
1544
|
BIBW 2992
|
EGFR and ErbB-2/HER2 tyrosine kinase inhibitor |
€50.00
|
|
1433
|
CI 1033
|
EGFR tyrosine kinase inhibitor |
€60.00
|
|
1537
|
CP 724714
|
ErbB-2/HER2 kinase inhibitor |
€80.00
|
|
3235
|
Dacomitinib
|
Potent irreversible pan-HER inhibitor |
€60.00
|
|
2680
|
EAI045
|
Allosteric EGFR inhibitor (L858R/T790M-specific) |
€105.00
|
|
1760
|
EGFR Inhibitor [879127-07-8]
|
Highly selective EGFR tyrosine kinase inhibitor |
€125.00
|
|
3192
|
EMI48
|
Inhibitor of EGFR triple mutants |
€125.00
|
|
1128
|
Erlotinib hydrochloride
|
EGFR tyrosine kinase inhibitor |
€70.00
|
|
1393
|
Gefitinib
|
EGFR tyrosine kinase inhibitor |
€70.00
|
|
1395
|
Lapatinib ditosylate
|
EGFR and ErbB-2/HER2 tyrosine kinase inhibitor |
€80.00
|
|
1526
|
Neratinib
|
EGFR and ErbB-2/HER2 tyrosine kinase inhibitor |
€80.00
|